Journal of Radioanalytical and Nuclear Chemistry
Volume/Issue:
Volume 290: Issue 3
Development of an in vivo radionuclide generator by labeling bleomycin with 191Os
Authors:
Mina Jamre Faculty of Nuclear Engineering and Physics, Amirkabir University of Technology, Tehran, Iran

Search for other papers by Mina Jamre in
Current site
Google Scholar
PubMed Close
,
Nafise Salek Faculty of Nuclear Engineering and Physics, Amirkabir University of Technology, Tehran, Iran

Search for other papers by Nafise Salek in
Current site
Google Scholar
PubMed Close
,
Amir Jalilian Radiopharmaceutical Research and Development Lab (RRDL), Nuclear Science and Technology Research Institute (NSTRI), 14155-1339 Tehran, Iran

Search for other papers by Amir Jalilian in
Current site
Google Scholar
PubMed Close
,
Leila Moghaddam Radiopharmaceutical Research and Development Lab (RRDL), Nuclear Science and Technology Research Institute (NSTRI), 14155-1339 Tehran, Iran

Search for other papers by Leila Moghaddam in
Current site
Google Scholar
PubMed Close
,
Mojtaba Shamsaee Faculty of Nuclear Engineering and Physics, Amirkabir University of Technology, Tehran, Iran

Search for other papers by Mojtaba Shamsaee in
Current site
Google Scholar
PubMed Close
,
Mohammad Mazidi Radiopharmaceutical Research and Development Lab (RRDL), Nuclear Science and Technology Research Institute (NSTRI), 14155-1339 Tehran, Iran

Search for other papers by Mohammad Mazidi in
Current site
Google Scholar
PubMed Close
, and
Mohammad Ghannadi-Maragheh Radiopharmaceutical Research and Development Lab (RRDL), Nuclear Science and Technology Research Institute (NSTRI), 14155-1339 Tehran, Iran

Search for other papers by Mohammad Ghannadi-Maragheh in
Current site
Google Scholar
PubMed Close
Pages:
543–549
Online Publication Date:
25 Jun 2011
Publication Date:
01 Dec 2011
Article Category:
Research Article
DOI:
https://doi.org/10.1007/s10967-011-1288-3
Restricted access

Abstract  

Bleomycin (BLM) has been labeled with various radioisotopes and widely used in therapy and diagnosis. 191Os is a parent radionuclide with 15.4 day half-life and decays by beta emission to 191mIr, which is a radionuclide with 4.96 s half-life. BLM was labeled with 191Os-hexachloro-osmate and its distribution and stability in wild-type mice was determined. The complex was obtained at the pH 2 in normal saline at 90 °C in 48 h. Radio-TLC showed an overall radiochemical yield of 93–97%, radio-chemical purity > 97%. The biodistribution study for 191Os-hexachloro-osmate and 191Os-BLM were carried in wild type-mice up to 14 days. Lungs, liver and spleen uptake increased 24–72 h after administration of 191Os-BLM. 24 h after administration, the radioactivity of the kidney increased and remained constant.

  • Collapse
  • Expand
Cover Journal of Radioanalytical and Nuclear Chemistry
Journal of Radioanalytical and Nuclear Chemistry
Print ISSN:
0236-5731
Online ISSN:
1588-2780

To see the editorial board, please visit the website of Springer Nature.

Manuscript Submission: HERE

For subscription options, please visit the website of Springer Nature.

Journal of Radionalytical and Nuclear Chemistry
Language English
Size A4
Year of
Foundation		 1968
Volumes
per Year		 1
Issues
per Year		 12
Founder Akadémiai Kiadó
Founder's
Address		 H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Publisher Akadémiai Kiadó
Springer Nature Switzerland AG
Publisher's
Address		 H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
CH-6330 Cham, Switzerland Gewerbestrasse 11.
Responsible
Publisher		 Chief Executive Officer, Akadémiai Kiadó
ISSN 0236-5731 (Print)
ISSN 1588-2780 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Jun 2023 1 0 0
Jul 2023 1 0 0
Aug 2023 4 0 0
Sep 2023 1 0 0
Oct 2023 1 3 0
Nov 2023 8 1 0
Dec 2023 0 0 0